In our study, we demonstrated the possibility of visually distinguishing the specific LATE hypometabolic pattern in individuals with aMCI, which can identify a subgroup of subjects distinct from AD and controls in terms of clinical severity, medial temporal atrophy, neocortical tau load, and cognitive decline. Here, MAPT is linked to Alzheimer disease.